echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > SinoVision, China Antibody and Genting Shinyao reached a global cooperation agreement on BTK inhibitors

    SinoVision, China Antibody and Genting Shinyao reached a global cooperation agreement on BTK inhibitors

    • Last Update: 2021-10-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On September 17, Sinovation, China Antibody and Genting Shinya announced that they have reached an exclusive global cooperation agreement, granting Genting Shinya the right to develop and commercialize XNW1011 (SN1011) worldwide in the field of kidney disease
    .

    XNW1011 is a new generation of covalent and reversible BTK inhibitor independently developed by Sinoville.
    It is undergoing clinical trials for tumor indications and is jointly conducting clinical research on autoimmune diseases with Chinese antibodies
    .


    XNW1011 is currently preparing to carry out phase II clinical trials for multiple indications


    This cooperation agreement with Everest has a down payment of 12 million U.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.